Specialties
Board Certification
|
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
|
Board Certification and Academic Information
| Academic Departments |
Pediatrics
-Assistant Professor (Clinical) |
|---|---|
| Academic Divisions |
Hematology/Oncology
|
| Board Certification |
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
|
Education history
| Undergraduate | Majors: Chemistry and Biology; Minors: Global Awareness and Business Development - Drury University | B.A. |
|---|---|---|
| Graduate Training | Biomedical Sciences - Kansas City University | M.S. |
| Professional Medical | Osteopathic Medicine - Kansas City University College of Osteopathic Medicine | D.O. |
| Residency | Pediatrics - Loyola University Medical Center | Resident |
| Fellowship | Pediatric Hematology/Oncology - Northwestern University Feinberg School of Medicine | Fellow |
| Fellowship | Osteosarcoma - Ann & Robert H. Lurie Children¿s Hospital | Clinical Research Fellow |
Selected Publications
Journal Article
- Sleiman MM Jr, Statman MR, Yockel MR, Wu YP, Hamilton JG, Kohlmann WK, Vagher J, Feola S, Maese LD, Chen J, Appel B, Mehrhoff CJ, Peshkin BN, Kadan-Lottick NS, Kupfer GM, Tercyak K (2025). Parental perspectives on the use of tumor molecular profiling and germline genetic testing during their children's cancer treatment. Familial cancer, 24(3), 63.
- Ramesh S, Dyer E, Pomaville M, Doytcheva K, Dolezal J, Kochanny S, Terhaar R, Mehrhoff CJ, Patel K, Brewer J, Kusswurm B, Naranjo A, Shimada H, Cipriani NA, Husain AN, Pytel P, Sokol EA, Cohn SL, George RE, Pearson AT, Applebaum MA (2024). Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology. NPJ Precis Oncol, 8(1), 255.
- Sargen MR, Barnhill RL, Elder DE, Swetter SM, Prieto VG, Ko JS, Bahrami A, Gerami P, Karunamurthy A, Pappo AS, Schuchter LM, LeBoit PE, Yeh I, Kirkwood JM, Jen M, Dunkel IJ, Durham MM, Christison-Lagay ER, Austin MT, Aldrink JH, Mehrhoff C, Hawryluk EB, Chu EY, Busam KJ, Sondak V, Messina J, Puig S, Colebatch AJ, Coughlin CC, Berrebi KG, Laetsch TW, Mitchell SG, Seynnaeve B (2024). Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.(Epub ahead of print) J Clin Oncol, JCO2401154.
- Applebaum M, Ramesh S, Dyer E, Pomaville M, Doytcheva K, Dolezal J, Kochanny S, Terhaar R, Mehrhoff C, Patel K, Brewer J, Kusswurm B, Naranjo A, Shimada H, Sokol E, Cohn S, George R, Pearson A (2024). Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology. Res Sq.
- Long CM, Mehrhoff C, Abdel-Latief E, Rech M, Laubham M (2021). Factors Influencing Pediatric Emergency Department Visits for Low-Acuity Conditions. Pediatr Emerg Care, 37(5), 265-268.
- Roy LN, Roy RN, Allen KA, Mehrhoff CJ, Henson IB, Stegner JM (2012). Buffer standards for the physiological pH of the zwitterionic compound of 3-(N-morpholino)propanesulfonic acid (MOPS) from T = (278.15 to 328.15) K. J Chem Thermodyn, 47, 21-27.
- Roy LN, Roy RN, Allen KA, Mehrhoff CJ, Henson IB, Stegner JM, Downs ZM (2012). Buffer Standards for the Physiological pH of N-(2-Hydroxyethyl)piperazine-N’-4-butanesulfonic Acid (HEPBS) from 5 to 55oC. Open Electrochemistry Journal, 4(1), 20-7.
- Roy RN, Roy LN, Allen KA, Mehrhoff CJ, Henson IB, Stegner JM, Jenkins AL, Shah AA, Rhocchio SD (2012). Buffers for the Physiological pH Range: Studies of 4-(N-Morpholino) butanesulfonic Acid (MOBS) from 5 to 55oC. J Solution Chem, 41(6), 1044-53.
- Roy LN, Roy RN, Wolen JT, Bwashi A, Stegner JM, Down ZM, Mehrhoff CJ, Bodendorfer BM, Allen KA, Harmon MA, Henson IB (2009). 3-[4-(2 Hydroxyethyl)-1-piperazinyl]propanesulfonic Acid (HEPPS) and the pH of its Buffer Solutions from (278.15 to 328.15)K. J Chem Eng Data, 55(3), 1327-32.
- JB Eyring BS, Christopher Nielson MD, Michelle Meder MD, Casey Mehrhoff DO, J. Fredrik Grimmer MD (Submitted for publication). Decreasing Incidence of Papillary Thyroid Carcinoma in Females Ages 15-18: A SEER database analysis. Laryngoscope.
Review
- Werk RS, Mehrhoff CJ, Badawy S (2025). Quality of Life and Adherence to Tyrosine Kinase Inhibitors Among Pediatric, Adolescent, and Young Adult Chronic Myeloid Leukemia Patients: A Systematic Review. Pediatric blood & cancer, e31686.
- Mehrhoff CJ, Vagher J, Florou V, Maese LD (2024). Genetic Predisposition to Sarcoma: What Should Clinicians Know? [Review]. Curr Treat Options Oncol, 25, (6), 769-783.
Case Report
- Huntsman A, Mims L, Gociman S, Mehrhoff C (2025). Primary intracranial malignant melanoma in a pediatric patient: A rare case report. JAAD case reports, 64, 37-39.
- Mehrhoff CJ, Hemenway CS, Suh E (2020). Emergence of a Ph-negative Clone in a Child With Ph+ ALL. J Pediatr Hematol Oncol, 42(6), e466-e468.
Letter
- Casey Mehrhoff, Urania Dagalakis, Andrew J Bauer, Priya Mahajan, Theodore W Laetsch, Sogol Mostoufi-Moa (2025). Navigating Multidisciplinary Care in Pediatric Thyroid Carcinoma: Insights From Children's Oncology Group Sites. pediatric blood and cancer,